Upon antiretroviral therapy (ART) human immunodeficiency virus (HIV)/human T-cell lymphotropic virus type 1 (HTLV-1) co-infected individuals frequently develop neurological disorders through hitherto unknown mechanisms. Here, we show that effective anti-HIV ART increases HTLV-1 proviral load through a polyclonal integration pattern of HTLV-1 in both CD4
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Upon antiretroviral therapy (ART) human immunodeficiency virus (HIV)/human T-cell lymphotropic virus type 1 (HTLV-1) co-infected individuals frequently develop neurological disorders through hitherto unknown mechanisms. Here, we show that effective anti-HIV ART increases HTLV-1 proviral load through a polyclonal integration pattern of HTLV-1 in both CD4
+ and CD8 + T-cell subsets that is reminiscent of that typically associated with HTLV-1-related inflammatory conditions. These data indicate that preventing ART-triggered clonal expansion of HTLV-1-infected cells in co-infected individuals deserves investigation.
In co-endemic areas, up to 10 % of HIV-1-infected individuals may be co-infected with HTLV-1 which is the causative agent of the adult T-cell leukaemia/lymphoma and number of inflammatory diseases, notably the HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/ TSP) (Berger et al., 1991; Gessain et al., 1985; Silva et al., 2012) . The lifetime risk of HAM/TSP in HTLV-1 individuals is about 2 %, but for hitherto unknown reasons this rate is higher in HIV-1/HTLV-1-co-infected patients (Beilke et al., 2005) and more particularly in those treated with antiretroviral therapy (ART) in whom the incidence of neurological complications ranges from 9 (Beilke et al., 2005) to 73 % (Harrison et al., 1997; Silva et al., 2012) .
In contrast with HIV-1, HTLV-1 promotes the persistent clonal expansion of CD4 + -and CD8 + -infected T-cells (Zane et al., 2009) . The number of circulating proviral copies and the clonality pattern of infected cells are two stage-specific markers of the infection (Mortreux et al., 2003) . Asymptomatic carriers display the lowest amount of HTLV-1 proviral loads (HPVLs) distributed among a limited number of low abundant clones, while HPVL is higher in HAM/TSP where it distributes among a significantly elevated number of more extensively expanded clones (Cavrois et al., 1996; Mortreux et al., 2001) . In HAM/TSP, expanded HTLV-1-positive andnegative lymphocytes cross the blood-brain barrier, leading to damage to the thoracic spinal cord (Levin et al., 2002; Mortreux et al., 2003) . ART has been reported to maintain and even increase the proviral load (HPVL) and the expression of HTLV-1 in HIV-1-co-infected patients (Beilke et al., 1998; Machuca et al., 2001; Murphy et al., 2003) , thereby raising the hypothesis that ART may augment the risk of neurological complications in these individuals by triggering a HAM/TSP-like pattern of HTLV-1 replication, i.e. an ART-triggered polyclonal increase in circulating HPVLs.
To test this hypothesis, we monitored changes in both circulating HPVL and clonality pattern of HTLV-1-infected cells during a time-course study of ART-treated HIV-1/HTLV-1-co-infected patients and control individuals. To this end, HIV-1-infected individuals (n5865) followed at the Cayenne Pasteur Institute (French Guyana) were tested for anti-HTLV antibodies and 45 (5.2 %) were found to be HTLV-1-positive. Three of these co-infected patients, #1154, #0433 and #1044, initiated ART and were monitored for HIV-1 RNA, HPVLs and clonality. The patients yielded a rapid decrease of HIV-1 viral loads with a drop to ,50 viral copies ml 21 that coincided with a global T-cell rebound (Table 1) . HIV-1 RNA remained undetectable during the follow-up period, indicating that upon ART, each patient demonstrated good suppression of HIV-1.
In contrast to the dramatic decrease of circulating HIV-1 RNA, Fig. 1(a) shows that for the three co-infected individuals, HPVLs were higher after the initiation of ART than before and increased as a function of time (R50.710, P,10 24 , Spearman's rank correlation). Statistical analysis of pooled data presented in Fig. 1 (a) revealed a mean increase in HPVL of 2.9-fold upon ART (P,10
24
, Mann-Whitney test). Noteworthy, although only indicative, the increase in HPVLs paralleled that of T-cell counts (Table 1) . We therefore further measured HPVLs in CD4
+ and CD8 + Tcells. Cell-sorting was performed as described previously (Sibon et al., 2006) and the mean purity of isolated T-cells was .92 %. As already described (Sibon et al., 2006) , CD4 +
T-cells harboured higher HPVLs than CD8
+ T-cells (Table  1) . In both T-cell subsets, HPVLs were higher after than before ART onset and increased as a function of time (CD4 + T-cells: R50.834, P50.005, CD8 + T-cells: R50.812, P50.008, Spearman's rank correlation). Ten HTLV-1-positive HIV-1-negative carriers and four HIV-1-negative HAM/TSP patients served as control (three to eight samples per individual). These have been described previously (Cavrois et al., 1996 (Cavrois et al., , 1998 Sibon et al., 2006) . No significant time-dependent fluctuation was observed (data not shown). Thus, in contrast to its negative effect on HIV-1 replication, ART in HIV-1/HTLV-1-co-infected patients coincides with increased HPVLs in both CD4
+ and CD8 + T-cells.
When compared to asymptomatic carriers, patients suffering from HAM/TSP typically have a significant higher number of circulating HTLV-1-positive clones and frequently possess additional large clones (Cavrois et al., 1996 (Cavrois et al., , 1998 (Cavrois et al., , 2000 Gillet et al., 2011; Mortreux et al., 2001 Mortreux et al., , 2003 Sibon et al., 2006) . We therefore tested whether HPVL modifications relied on specific qualitative and/or quantitative changes in the clonality pattern of infected cells. This was assessed through semi-quantitative quadruplicate LMPCR amplification of 39 HTLV-1 proviral sequences (Cavrois et al., 1995) in samples collected over time, before and upon ART. As shown in Fig. 1(b) , a clonal distribution of HTLV-1-bearing PBMCs was evidenced in all samples, with a wide variation in the number of circulating infected clones between individuals. In contrast to HIV-1 RNA but in accordance to HPVLs, the number of circulating clones increased with time upon ART (Table 1 ). Significant correlation linked the HPVLs with the number of clones (R50.931, P ,10 24 , Spearman's rank correlation) including that of abundant clones (R50.898, P ,10 24 , Spearman's rank correlation), which was in mean 2.3-fold higher after than before ART initiation. In comparison, no fluctuation of the overall number of circulating clones was observed with the 14 control individuals followed-up over time (data not shown). Moreover, although small numbers of paired samples were tested, the difference in HPVLs between CD4
+ and CD8 + subsets pertained more to the number of abundant clones (mean 13.00 in CD4
+ T-cells vs 1.5 in CD8
+ T-cells, P50.026, paired sample t-test) than with the overall number of clones (40 vs 29.75, NSD) . This suggests that the ART-related increase of HPVLs mainly relies on a strengthened clonal expansion of the two T-cell reservoirs for HTLV-1.
In conclusion, our results indicate that, while ART stably decreases HIV-1 replication, it progressively increases HPVLs through an enhanced polyclonal expansion of HTLV-1-infected T-cells, including both CD4
+ and CD8
+ subsets, as a typical inflammatory-like pattern of HTLV-1 replication (Cavrois et al., 1996 (Cavrois et al., , 1998 (Cavrois et al., , 2000 Gillet et al., 2011; Mortreux et al., 2001 Mortreux et al., , 2003 Sibon et al., 2006) . Initially coinciding with ART-mediated T-cell reconstitution, changes in HTLV-1 clonality evolved with time, suggesting that the ART duration might constitute a risk for long-term complications such as HTLV-1-associated neurological diseases. Supporting this, recent work has shown that 12 of 47 (25.5 %) co-infected patients developed myelopathy upon ART (Silva et al., 2012) . Beilke and colleagues have reported that in HIV-1/HTLV-1/2 co-infected individuals, HPVLs were not significantly different between ART-treated versus non-treated patients (Beilke et al., 2007) . Recently, Silva and colleagues showed no significant difference in HPVLs between HIV-1/HTLV-1 co-infected patients upon ART and untreated HTLV-1 carriers (Silva et al., 2012) . A distinctive feature of the present work compared to the former ones is the longitudinal analysis of HTLV-1 replication with samples collected from co-infected individuals before and over an extended time period of ART (up to 31 months). This approach allows taking into account the high fluctuation of HPVLs among HIV-1/HTLV-1 carriers to more confidently assess the impact of ART. Owing to this, our results provide the first line of evidence that ART promotes a HAM/TSP-like pattern of HTLV-1 replication in HIV-1/ HTLV-1-co-infected individuals. The mechanisms allowing the ART-associated replication of HTLV-1 remain to be elucidated. However, one can propose that the ART-related immune reconstitution could significantly boost the cellassociated replication of HTLV-1 in both CD4 + and CD8 + subsets causing a polyclonal pattern of circulating infected cells and subsequent elevated levels of HTLV-1 proviral loads. The present study did not enrol any HTLV-1 mono-infected patients under ART thereby our results do Journal of General Virology 94 Quadruplicate LMPCR was performed with the DNA of PBMCs harvested over time. Quadruplicate LMPCR was performed as described previously (Cavrois et al., 1995) with the DNA of PBMCs harvested over time. For each sample, 2 mg DNA was studied through four experiments. After digestion by NlaIII, linear and exponential amplification, 10 cycles of linear PCR were performed with a 59-32 P-radiolabelled HTLV-1 positivestrand-specific primer. Radiolabelled PCR products were resolved on denaturing PAGE and revealed by autoradiography. Time points are annotated according to the corresponding ART duration (month) (bottom). Each band corresponds to a cluster of identical HTLV-1 flanking sequence. Since HTLV-1 does not integrate in a specific region of the cellular genome, each signal corresponds to a cluster of proviruses sharing the same integration site and thus derived from a single HTLV-1-infected progenitor. The abundance of each clone is proportionate to its frequency of detection after quadruplicate experiment. Accordingly, clones detected once, two to three times, and four times correspond to 50-100, 100-500 and more than 500 copies in 1 mg of DNA, respectively (Cavrois et al., 1995) . The total number of clones and the number of abundant clones (those detected more than once over four experiments) are presented in Table 1 . not presume that ART treatment without HIV-1 coinfection could produce similar effects. Further longitudinal investigations are needed to assess whether or not the ART-induced polyclonal expansion of HTLV-1-infected cells might be predictive for neurological disease outcome in HIV-1/HTLV-1-co-infected individuals.
